ipamorelin increases igf-1 + Tesamorelin CJC-1295 / Ipamorelin: Benefits, How
Description
Moreover, TP53 was altered in 12.4% and 6.4% of first-relapse childhood ALL patients with B-cell precursor ALL and T-cell ALL, respectively, with approximately half of the TP53 alterations gained at relapse [345]
,
Three biological replicates for each group were tested and each reaction was performed with three technical replicates
All procedures and protocols were performed according to the Declaration of Helsinki
